LWM
BSX icon

Laidlaw Wealth Management’s Boston Scientific BSX Stock Holding History

Laidlaw Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,180
Closed -$258K – 237
2020
Q4 		$258K Sell
7,180
-700
-9% -$25.2K 0.05% 290
2020
Q3 		$301K Buy
7,880
+900
+13% +$34.7K 0.13% 152
2020
Q2 		$245K Buy
6,980
+130
+2% +$4.68K 0.13% 153
2020
Q1 		$224K Sell
6,850
-1,250
-15% -$48.8K 0.15% 134
2019
Q4 		$366K Buy
+8,100
New +$339K 0.23% 111

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Laidlaw Wealth Management's BSX Position: Q1 2021 in Review

Laidlaw Wealth Management sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 7,180 shares — an estimated $258K sold.

Laidlaw Wealth Management first reported a position in BSX in Q4 2019 and held it in 5 quarters. The position peaked at $366K in Q4 2019. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Laidlaw Wealth Management reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Laidlaw Wealth Management sold 7,180 Boston Scientific shares in Q1 2021, an estimated $258K.
  • Laidlaw Wealth Management first reported a position in Boston Scientific in Q4 2019 and held it in 5 quarters.
  • Laidlaw Wealth Management's Boston Scientific position peaked at $366K in Q4 2019.
  • 830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Laidlaw Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.